Technical Analysis for ENLV - Enlivex Therapeutics Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 10.50% | |
Expansion Breakdown | Bearish Swing Setup | 10.50% | |
Lower Bollinger Band Walk | Weakness | 10.50% | |
New 52 Week Low | Weakness | 10.50% |
Alert | Time |
---|---|
Possible Inside Day | about 13 hours ago |
Rose Above Lower Bollinger Band | about 18 hours ago |
Up 5% | about 18 hours ago |
Up 3% | about 18 hours ago |
Down 1% | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/09/2024
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.59 |
52 Week Low | 0.8101 |
Average Volume | 155,029 |
200-Day Moving Average | 1.86 |
50-Day Moving Average | 1.40 |
20-Day Moving Average | 1.20 |
10-Day Moving Average | 1.06 |
Average True Range | 0.12 |
RSI (14) | 26.47 |
ADX | 40.27 |
+DI | 4.80 |
-DI | 28.70 |
Chandelier Exit (Long, 3 ATRs) | 1.29 |
Chandelier Exit (Short, 3 ATRs) | 1.17 |
Upper Bollinger Bands | 1.53 |
Lower Bollinger Band | 0.86 |
Percent B (%b) | 0.11 |
BandWidth | 56.72 |
MACD Line | -0.14 |
MACD Signal Line | -0.11 |
MACD Histogram | -0.0301 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.08 | ||||
Resistance 3 (R3) | 1.06 | 1.00 | 1.06 | ||
Resistance 2 (R2) | 1.00 | 0.96 | 1.01 | 1.05 | |
Resistance 1 (R1) | 0.96 | 0.93 | 0.98 | 0.98 | 1.04 |
Pivot Point | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 |
Support 1 (S1) | 0.86 | 0.86 | 0.88 | 0.88 | 0.82 |
Support 2 (S2) | 0.79 | 0.83 | 0.80 | 0.81 | |
Support 3 (S3) | 0.76 | 0.79 | 0.80 | ||
Support 4 (S4) | 0.78 |